The global nucleic acid amplification testing market size is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.
These
tests are currently being used extensively for screening and diagnosis of a
wide range of infectious diseases. Along with known infectious diseases,
management of epidemics of new diseases has caused a sudden surge in the demand
for advanced diagnostic tests. NAAT is currently the most advanced and
efficient diagnostic method, which extensively uses technology that helps in
reducing procedural time and consumption of reagents.
Full Research Report On Nucleic Acid Amplification Testing Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/nucleic-acid-amplification-testing-naat-market
Nucleic Acid
Amplification Test Market Report Highlights
- The market study suggests
that infectious diseases segment captured the largest revenue share in
2015 owing to the high demand for effective screening methods for
management of these diseases
- Cancer is expected to
exhibit the fastest growth during the forecast period due to the rising
number of studies to develop tests for early detection of various cancer
types
- Expanding applications
prenatal screening and for the detection of mitochondrial disorders is
expected to boost the demand for NAAT
- High usage of the PCR
technique in NAT is driving the growth of the segment and is expected to
capture significant revenue share in the near future
- North America dominated the
space in 2015 with U.S. capturing the largest share
- Evolution of biotechnology
sector in the Asia Pacific, along with the favorable government
initiatives, Asia Pacific is expected to show the fastest growth rate
during the forecast period
- A few of the major players
in the market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.;
Becton, Dickinson and Company; Novartis AG; Beckman Coulter, Inc.;
bioMérieux SA; Abbott Laboratories; Siemens Healthineers, and Illumina,
Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/nucleic-acid-amplification-testing-naat-market/request/rs1
Nucleic Acid
Amplification Test Market Segmentation
Grand View Research has segmented
the nucleic acid amplification test market on the basis of application,
technique, and region:
Nucleic Acid
Amplification Test Application Outlook (Revenue, USD Million, 2014 - 2025)
- Infectious Diseases
- Virus
- Bacteria
- Others
- Cancer
- Personalized Medicine
- Genetic and Mitochondrial
Disorders
Nucleic Acid
Amplification Test Technique Outlook (Revenue, USD Million 2014 - 2025)
- Target amplification systems
- Probe amplification systems
- Signal amplification
Nucleic Acid
Amplification Test Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Germany Asia Pacific
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment